These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 29690793)

  • 1. Clinical Implementation of Pharmacogenetic Decision Support Tools for Antidepressant Drug Prescribing.
    Zeier Z; Carpenter LL; Kalin NH; Rodriguez CI; McDonald WM; Widge AS; Nemeroff CB
    Am J Psychiatry; 2018 Sep; 175(9):873-886. PubMed ID: 29690793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetic guidelines and decision support tools for depression treatment: application to late-life.
    Chang DD; Eyreeuro HA; Abbott R; Coudreaut M; Baune BT; Shaman JA; Lavretsky H; Lenze EJ; Merrill DA; Singh AB; Mulsant BH; Reynolds CF; Müller DJ; Bousman C
    Pharmacogenomics; 2018 Nov; 19(16):1269-1284. PubMed ID: 30422065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials.
    Bousman CA; Arandjelovic K; Mancuso SG; Eyre HA; Dunlop BW
    Pharmacogenomics; 2019 Jan; 20(1):37-47. PubMed ID: 30520364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant prescribing in the precision medicine era: a prescriber's primer on pharmacogenetic tools.
    Bousman CA; Forbes M; Jayaram M; Eyre H; Reynolds CF; Berk M; Hopwood M; Ng C
    BMC Psychiatry; 2017 Feb; 17(1):60. PubMed ID: 28178974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Pharmacogenomic Testing Improve Clinical Outcomes for Major Depressive Disorder? A Systematic Review of Clinical Trials and Cost-Effectiveness Studies.
    Rosenblat JD; Lee Y; McIntyre RS
    J Clin Psychiatry; 2017 Jun; 78(6):720-729. PubMed ID: 28068459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics in Child and Adolescent Psychiatry: Background and Evidence-Based Clinical Applications.
    Malik S; Verma P; Ruaño G; Al Siaghy A; Dilawar A; Bishop JR; Strawn JR; Namerow LB
    J Child Adolesc Psychopharmacol; 2024 Feb; 34(1):4-20. PubMed ID: 38377525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Probability of Gene-Drug Interactions Associated with Medication Side Effects in Adolescent Depression: Results from a Randomized Controlled Trial of Pharmacogenetic Testing.
    Nooraeen S; Croarkin PE; Geske JR; Shekunov J; Orth SS; Romanowicz M; Frye MA; Vande Voort JL
    J Child Adolesc Psychopharmacol; 2024 Feb; 34(1):28-33. PubMed ID: 38377526
    [No Abstract]   [Full Text] [Related]  

  • 8. Does obtaining CYP2D6 and CYP2C19 pharmacogenetic testing predict antidepressant response or adverse drug reactions?
    Solomon HV; Cates KW; Li KJ
    Psychiatry Res; 2019 Jan; 271():604-613. PubMed ID: 30554109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical utility of combinatorial pharmacogenomic testing for patients with depression: a meta-analysis.
    Brown L; Vranjkovic O; Li J; Yu K; Al Habbab T; Johnson H; Brown K; Jablonski MR; Dechairo B
    Pharmacogenomics; 2020 Jun; 21(8):559-569. PubMed ID: 32301649
    [No Abstract]   [Full Text] [Related]  

  • 10. Thoughtful Clinical Use of Pharmacogenetics in Child and Adolescent Psychopharmacology.
    Ramsey LB; Namerow LB; Bishop JR; Hicks JK; Bousman C; Croarkin PE; Mathews CA; Van Driest SL; Strawn JR
    J Am Acad Child Adolesc Psychiatry; 2021 Jun; 60(6):660-664. PubMed ID: 32860906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomic Clinical Support Tools for the Treatment of Depression.
    Baum ML; Widge AS; Carpenter LL; McDonald WM; Cohen BM; Nemeroff CB;
    Am J Psychiatry; 2024 Jul; 181(7):591-607. PubMed ID: 38685859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes.
    Altar CA; Carhart JM; Allen JD; Hall-Flavin DK; Dechairo BM; Winner JG
    Pharmacogenomics J; 2015 Oct; 15(5):443-51. PubMed ID: 25686762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Providers' Use of Pharmacogenetic Testing to Inform Antidepressant Prescribing: Results of Qualitative Interviews.
    Vest BM; Wray LO; Thase ME; Brady LA; Chapman SR; Oslin DW
    Psychiatr Serv; 2023 Dec; 74(12):1270-1276. PubMed ID: 37528698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of depression pharmacogenetic decision support tools in shared decision making.
    Arandjelovic K; Eyre HA; Lenze E; Singh AB; Berk M; Bousman C
    J Neural Transm (Vienna); 2019 Jan; 126(1):87-94. PubMed ID: 29082439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetic/Pharmacogenomic Tests for Treatment Prediction in Depression.
    Islam F; Gorbovskaya I; Müller DJ
    Adv Exp Med Biol; 2021; 1305():231-255. PubMed ID: 33834403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomic testing and personalized treatment of depression.
    Perlis RH
    Clin Chem; 2014 Jan; 60(1):53-9. PubMed ID: 24281779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of wide-scale pharmacogenetic testing in primary care.
    Natasha Petry ; Baye J; Aifaoui A; Wilke RA; Lupu RA; Savageau J; Gapp B; Massmann A; Hahn D; Hajek C; Schultz A
    Pharmacogenomics; 2019 Aug; 20(12):903-913. PubMed ID: 31453774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetic testing among patients with depression in a US managed care population.
    Anderson HD; Thant TM; Kao DP; Crooks KR; Mendola ND; Aquilante CL
    Clin Transl Sci; 2022 Jul; 15(7):1644-1653. PubMed ID: 35385214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roadmap for Routine Pharmacogenetic Testing in a Psychiatric University Hospital.
    Menke A; Weber H; Deckert J
    Pharmacopsychiatry; 2020 Jul; 53(4):179-183. PubMed ID: 31185510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression.
    Rothschild AJ; Parikh SV; Hain D; Law R; Thase ME; Dunlop BW; DeBattista C; Conway CR; Forester BP; Shelton RC; Macaluso M; Brown K; Lewis D; Gutin A; Jablonski MR; Greden JF
    Psychiatry Res; 2021 Feb; 296():113649. PubMed ID: 33360967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.